Effect of Acupoint Catgut Embedding for Middle-Aged Obesity: A Multicentre, Randomised, Sham-Controlled Trial

Table 3

Results of the sensitivity for the primary outcome.

Time point	Percentage of reduction from baseline (%); Adjusted mean (95% confidence interval),			Continuous time in mixed-effects model; Coefficient (95% confidence interval),
	ACE group	Sham ACE group	Difference	Group	Time	Group Time
4 weeks	1.90 (1.26, 2.54), <0.001	1.80 (1.14, 2.46), <0.001	0.10 (-0.81, 1.02), 0.824
8 weeks	4.37 (3.59, 5.15), <0.001	2.92 (2.12, 3.73), <0.001	1.45 (0.33, 2.57), 0.012
12 weeks	6.20 (5.37, 7.03), <0.001	3.77 (2.92, 4.62), <0.001	2.43 (1.24, 3.62), <0.001
16 weeks	8.93 (8.08, 9.78), <0.001	3.87 (3.01, 4.74), <0.001	5.06 (3.84, 6.28), <0.001	0.88 (-0.84, 2.61), 0.313	0.01 (-0.01, 0.03), 0.443	0.08 (0.05, 0.12), <0.001
28 weeks	8.58 (7.72, 9.45), <0.001	3.85 (2.97, 4.74), <0.001	4.73 (3.50, 5.96), <0.001
40 weeks	8.58 (7.67, 9.49), <0.001	3.25 (2.32, 4.19), <0.001	5.33 (4.02, 6.63), <0.001
Overall	6.43 (5.74, 7.12), <0.001	3.25 (2.53, 3.96), <0.001	3.18 (2.18, 4.18), <0.001

Percentage of reduction from baseline = (before value − after value)/before value ^∗ 100%.